- Home>
- Specialties>
- HIV/AIDS Clinical Care>
- Top Stories
Top Stories for HIV/AIDS
TOP STORY
The Prospect of PrEP
- December 29, 2008
- Salim S. Abdool Karim, MD, PhD
- HIV/AIDS Clinical Care
The use of antiretrovirals for pre-exposure prophylaxis is being widely investigated. What if it’s found to be safe and effective?
TOP STORY
Rapid HIV Testing Is Not Without Its Flaws
- December 29, 2008
- Abigail Zuger, MD
- HIV/AIDS Clinical Care
The low specificity of the oral swab tests remains a concern, as do poor follow-up rates among those testing positive.
TOP STORY
Antiretroviral Rollout — Successes and ChallengesFree
- December 29, 2008
- Gerald H. Friedland, MD
- HIV/AIDS Clinical Care
The continued success of ART rollout programs will depend on efforts to prevent resistance and ensure adequate follow-up.
TOP STORY
HIV Incidence in the U.S.: New Methods Result in a Higher Estimate
- December 29, 2008
- Judith Feinberg, MD
- HIV/AIDS Clinical Care
Overall, the number of new infections in the U.S. is holding steady but is higher than we originally thought.
TOP STORY
No Good News Yet on Anti-HIV Microbicides
- December 29, 2008
- Sonia Nagy Chimienti, MD
- HIV/AIDS Clinical Care
Two intravaginal microbicide gels were found to be safe but completely ineffective.
TOP STORY
Crash and Burn of HIV Vaccine Candidates
- December 29, 2008
- Carlos del Rio, MD
- HIV/AIDS Clinical Care
The focus of HIV vaccine research was redefined in 2008.
TOP STORY
Newer Drugs Strikingly Effective When Given Together
- December 29, 2008
- Paul E. Sax, MD
- HIV/AIDS Clinical Care
Regimens that contain at least two of four recently approved drugs — darunavir, maraviroc, raltegravir, and etravirine — have yielded spectacular results in uncontrolled studies.
TOP STORY
Beyond Abacavir/3TC: Good News on First-Line Regimens
- December 29, 2008
- Charles B. Hicks, MD
- HIV/AIDS Clinical Care
Positive data emerged this year to support the use of boosted atazanavir and boosted darunavir in treatment-naive patients; raltegravir also looks promising in this population.
TOP STORY
Abacavir Turmoil
- December 29, 2008
- Helmut Albrecht, MD
- HIV/AIDS Clinical Care
Both the safety and efficacy of this NRTI were drawn into question in 2008.
TOP STORY
Earlier HIV Treatment Is Gaining Momentum
- December 29, 2008
- Keith Henry, MD
- HIV/AIDS Clinical Care
Evidence accumulated in 2008 to support starting ART at CD4 counts >350 cells/mm3.
